124 related articles for article (PubMed ID: 16907931)
1. Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy.
Undas A; Brummel-Ziedins KE; Potaczek DP; Stobierska-Dzierzek B; Bryniarski L; Szczeklik A; Mann KG
J Thromb Haemost; 2006 Nov; 4(11):2397-404. PubMed ID: 16907931
[TBL] [Abstract][Full Text] [Related]
2. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease.
Undas A; Celinska-Löwenhoff M; Löwenhoff T; Szczeklik A
J Thromb Haemost; 2006 May; 4(5):1029-36. PubMed ID: 16689755
[TBL] [Abstract][Full Text] [Related]
3. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group
BMC Pediatr; 2009 Dec; 9():79. PubMed ID: 20017932
[TBL] [Abstract][Full Text] [Related]
4. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
[TBL] [Abstract][Full Text] [Related]
6. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
Ostad MA; Eggeling S; Tschentscher P; Schwedhelm E; Böger R; Wenzel P; Meinertz T; Munzel T; Warnholtz A
Atherosclerosis; 2009 Jul; 205(1):227-32. PubMed ID: 19150064
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
Lauten WB; Khan QA; Rajagopalan S; Lerakis S; Rahman ST; Parthasarathy S; Khan BV
Am J Cardiol; 2003 May; 91(9):1116-9. PubMed ID: 12714159
[No Abstract] [Full Text] [Related]
8. Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.
Walter T; Szabo S; Suselbeck T; Borggrefe M; Lang S; Swoboda S; Hoffmeister HM; Dempfle CE
Clin Drug Investig; 2010; 30(7):453-60. PubMed ID: 20441243
[TBL] [Abstract][Full Text] [Related]
9. Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease.
Colivicchi F; Tubaro M; Mocini D; Genovesi Ebert A; Strano S; Melina G; Uguccioni M; Santini M
Curr Med Res Opin; 2010 Jun; 26(6):1277-84. PubMed ID: 20367555
[TBL] [Abstract][Full Text] [Related]
10. Effects of Atorvastatin Dose and Concomitant Use of Angiotensin-Converting Enzyme Inhibitors on Renal Function Changes over Time in Patients with Stable Coronary Artery Disease: A Prospective Observational Study.
Wieczorek-Surdacka E; Świerszcz J; Surdacki A
Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848655
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia.
Wierzbicki AS; Lumb PJ; Chik G; Crook MA
Am J Cardiol; 2001 Feb; 87(3):338-40, A9. PubMed ID: 11165973
[TBL] [Abstract][Full Text] [Related]
12. The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction.
Bank AJ; Kelly AS; Kaiser DR; Crawford WW; Waxman B; Schow DA; Billups KL
Vasc Med; 2006 Nov; 11(4):251-7. PubMed ID: 17390549
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
Schmermund A; Achenbach S; Budde T; Buziashvili Y; Förster A; Friedrich G; Henein M; Kerkhoff G; Knollmann F; Kukharchuk V; Lahiri A; Leischik R; Moshage W; Schartl M; Siffert W; Steinhagen-Thiessen E; Sinitsyn V; Vogt A; Wiedeking B; Erbel R
Circulation; 2006 Jan; 113(3):427-37. PubMed ID: 16415377
[TBL] [Abstract][Full Text] [Related]
14. Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload.
Xia J; Qu Y; Shen H; Liu X
Cardiology; 2014; 128(3):285-92. PubMed ID: 24903511
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
16. The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease.
Potaczek DP; Undas A; Iwaniec T; Szczeklik A
Thromb Haemost; 2005 Jul; 94(1):224-5. PubMed ID: 16116691
[No Abstract] [Full Text] [Related]
17. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow.
Caliskan M; Erdogan D; Gullu H; Topcu S; Ciftci O; Yildirir A; Muderrisoglu H
Clin Cardiol; 2007 Sep; 30(9):475-9. PubMed ID: 17803205
[TBL] [Abstract][Full Text] [Related]
19. Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging.
Komiyama N
Circ J; 2009 Apr; 73(4):628-9. PubMed ID: 19318726
[No Abstract] [Full Text] [Related]
20. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.
Bangalore S; Fayyad R; Laskey R; DeMicco D; Deedwania P; Kostis JB; Messerli FH;
Eur Heart J; 2014 Jul; 35(27):1801-8. PubMed ID: 23990605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
